How much funding has NeuroX1 raised?

NeuroX1 has raised $1.8M in total funding, most recently a Series C round.

Who are NeuroX1's investors?

NeuroX1's investors include Capital Factory, Techstars, Drive Capital.

Where is NeuroX1 headquartered?

NeuroX1 is headquartered in Austin, Texas, United States.

What industry is NeuroX1 in?

NeuroX1 operates in Artificial Intelligence, Healthcare, Biotech.

NeuroX1

The new standard in computational neuroscience

Austin, United States · Founded 2024 · $1.8M raised

Artificial Intelligence

Healthcare

Biotech

Headquarters: Austin, Texas
Employees: 1–10
Founded: 2024
Business Model: B2B

Website: neurox1.com
Total Funding: $1.8M
Last Round: $500K Series CJun 2024
Rounds: 5

About

NeuroX1 is a computational neuroscience and drug discovery company building a platform to identify drivers of neurodegenerative and neurological diseases using proprietary generative AI algorithms. The platform employs deep reinforcement learning to generate novel drug compounds tailored to specific therapeutic parameters, targeting conditions such as Alzheimer's and ALS. Founded in 2021 by Maxwell Dordevic, Conner Myers, and Lucas Myers in Austin, Texas. The company raised $1.83M across multiple seed rounds from Drive Capital, Trousdale Ventures, and others. NeuroX1 participated in Techstars Knoxville.

Summary

NeuroX1 is an Artificial Intelligence company based in Austin, United States, founded in 2024. It has raised $1.8M in total across 5 rounds, most recently a $500K Series C round in Jun 2024. Investors include Capital Factory, Techstars and Drive Capital.

LinkedIn X (Twitter)